Regional Program in partnership with Seattle Cancer Care Alliance
Saturday, December 14, 2013
Pelton Auditorium, SCCA/FCHRC
Seattle, WA
Presentations included allotted time for Audience Response System (ARS) assisted audience interaction as well as general question and answer time. |
|
7:00 am - 8:00 am | Registration |
7:00 am - 8:00 am | Continental Breakfast |
8:00 am - 8:10 am | Welcome and Introductions Kim A. Margolin, MD - Seattle Cancer Care Alliance |
8:10 am - 8:35 am | Immunology 101 for the Non-Immunologist Andrew D. Weinberg, PhD - Earle A. Chiles Research Institute, Providence Portland Medical Center |
8:35 am - 9:00 am | Immunology & Immunotherapy of Viral-Related Cancers Paul Nghiem, MD, PhD - University of Washington |
9:00 am - 9:25 am | Interleukin-2 and Related Cytokines: Indications and Clinical Management Brendan D. Curti, MD - Earle A. Chiles Research Institute, Providence Cancer Center |
9:25 am - 9:40 am | Break |
9:40 am - 10:15 am | Ipilimumab: Indications and Clinical Management Shailender Bhatia, MD - University of Washington |
10:15 am - 10:50 am | The PD-1/PD-L1 Pathway as a Target in Tumor Immunotherapy Scott S. Tykodi, MD, PhD - University of Washington and Fred Hutchinson Cancer Research Center |
10:50 am - 11:25 am | Cancer Vaccines Keith S. Bahjat, PhD - Earle A. Chiles Research Institute, Providence Cancer Center |
11:25 am - 11:50 am | Panel Discussion |
11:50 am - 12:20 pm | Lunch |
12:20 pm - 12:45 pm | Prediction: Cancer Immunotherapy in 10 Years **Non-CME** Martin A. Cheever, MD - Fred Hutchinson Cancer Research Center |
12:45 pm - 1:20 pm | Adoptive T Cell Therapy Sylvia M. Lee, MD - Fred Hutchinson Cancer Research Center |
1:20 pm - 1:55 pm | The Emerging Role of Combination Tumor Immunotherapy with Radiation Marka R. Crittenden, MD, PhD - Earle A. Chiles Research Institute, Providence Cancer Center |
1:55 pm - 2:30 pm | Immunoconjugate Principles and Application Hannah M. Linden, MD, FACP - University of Washington |
2:30 pm - 2:55 pm | Panel Discussion |
2:55 pm - 3:00 pm | Closing Remarks Walter J. Urba, MD, PhD - Earle A. Chiles Research Institute, Providence Cancer Center |
All presentations are licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.